Chemoprophylaxis for pulmonary aspergillosis during intensive chemotherapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8129437.
- Also identified by PMC identifier 1029718.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Three children who developed pulmonary aspergillosis while being treated for leukaemia or non-Hodgkin's lymphoma. Each child continued with intensive myelosuppressive chemotherapy regimens during the infection and each was successfully treated with antifungal prophylaxis based on itraconazole by mouth. Amphotericin B was also given during periods of severe neutropenia. No reactivation of the fungal infection was seen.
Medical subject headings
- Antineoplastic Agents
- Aspergillosis
- Lung Diseases, Fungal
- Opportunistic Infections